Maud Babau

Title: Maud Babau: Innovator in Sphingolipid Production

Introduction

Maud Babau is a notable inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biochemistry, particularly in the production of sphingolipids and related compounds. With two patents to her name, her work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Maud Babau's latest patents include a method for producing sphingoid bases or sphingolipids. This innovative method utilizes yeast to cultivate an objective substance, which is achieved by using a culture medium that contains an additive capable of associating with, binding to, solubilizing, and capturing the objective substance. The process involves collecting the objective substance from the yeast cells and/or the culture medium. Another patent focuses on the production of phytosphingosine or sphinganine, also using yeast. In this method, the yeast is modified to reduce the expression and/or activities of proteins encoded by the LCB4 and CKA2 genes, allowing for the collection of the desired objective substance.

Career Highlights

Throughout her career, Maud has worked with prominent companies such as Ajinomoto Co., Ltd. and Evolva SA. Her experience in these organizations has contributed to her expertise in biotechnological innovations and patent development.

Collaborations

Maud has collaborated with several professionals in her field, including Markus Schwab and Corina Daniela Wirdnam. These collaborations have likely enriched her research and development efforts, leading to her successful patent applications.

Conclusion

Maud Babau stands out as an innovative inventor in the realm of sphingolipid production. Her patents reflect her commitment to advancing biotechnological methods and contribute to the ongoing development of valuable substances in the industry.